Clinical Trial Finds Psilocybin Eases Depression in Cancer Patients
Clinical trial results reveal that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients, with effects lasting up to two years. Larger studies are underway to confirm its therapeutic potential.
Recent clinical trial results have demonstrated that a single dose of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, can offer long-lasting relief from depression and anxiety for individuals battling cancer. The study, published in the journal Cancer, involved 28 patients diagnosed with cancer and major depressive disorder. Participants received psychological support before, during, and after administering a 25-mg dose of psilocybin.
Follow-up assessments conducted two years later revealed significant benefits: over half of the patients experienced substantial reductions in depression, with nearly half maintaining remission. Additionally, about 43% of patients showed decreased anxiety levels. The findings suggest that psilocybin can have enduring antidepressant effects following just a single dose.
An ongoing double-blind trial is now exploring whether up to two doses of psilocybin at 25 mg can further improve outcomes in depression and anxiety among cancer patients. This larger study aims to determine if repeated dosing can increase the rate of remission.
Lead researcher Dr. Manish Agrawal from Sunstone Therapies highlighted the potential of psilocybin, noting that it could become a valuable treatment option for depression in cancer patients if further studies confirm these promising results. The research builds on previous work indicating the long-term mental health benefits of psilocybin, and ongoing investigations may pave the way for its broader use in supportive cancer care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Transforming Communication: How Healthcare Staff Can Improve Interactions with People Living with Dementia
A new study reveals how changing language used by healthcare staff can improve care, humanize interactions, and foster dignity for people living with dementia. Learn how empathetic communication can make a difference.
Resilience as a Key Factor in Mitigating Emotional Challenges in Girls with Juvenile Fibromyalgia
A recent study reveals that resilience significantly protects emotional health and brain function in girls with juvenile fibromyalgia, opening new avenues for psychological interventions to improve their quality of life.
Adolescents Make Up a Quarter of the Global Population: Key Health and Well-Being Trends Highlighted in New Report
A groundbreaking report by The Lancet reveals key health improvements among adolescents while highlighting emerging challenges like mental health disorders and climate impacts, urging global action to secure their well-being.
Increasing Use of Talk Therapy Reduces Dependence on Psychiatric Medications
Recent research shows a growing reliance on talk therapy and a decline in psychiatric medication use among Americans seeking mental health care, highlighting a shift towards more holistic treatment approaches.